A leading North East independent law firm has advised NVM Private Equity on their £2.75m investment of growth capital into Reading-based pharmaceutical company Ridge Pharma Limited. The balance of the £3.2m funding round was provided by existing investors and private individuals.

Corporate specialists at Muckle LLP, a Newcastle-based national law firm with a strong track record in the pharmaceutical sector, advised NVM on the technical legal elements of the deal.

Ridge Pharma is an emerging UK pharmaceutical business set to commercialise their first product in late 2018, with further launches to follow. Founded in 2017 by Chief Executive Officer Brendon McDonagh and Non-Executive Chairman, Harry Stratford, Ridge Pharma is focused on the in-licensing and marketing of prescription medicines.

Harry Stratford OBE has over 40 years’ experience in the pharmaceutical industry and Brendon, who has over 20 years of commercial experience in the sector, is passionate about challenging established prescription markets for the benefit of the NHS and patients.

Brendon said: “We are delighted to have NVM Private Equity as our partner in building a leading UK pharmaceutical company. From the outset they have shared and supported our ambition to build a sustainable business, with strong ethical principles, that delivers exceptional value to all our stakeholders, from patients to our employees.”

Aaron Lawson-Clark, Investment Associate of NVM Private Equity, said: “NVM is delighted to be backing Brendon and Harry in the development of a new competitive force in UK pharmaceuticals. We are backing a team with considerable experience and an excellent track record. Ridge have some exciting and disruptive plans and NVM looks forward to supporting the team as they drive towards developing a leading, ethical pharmaceutical business.”

Muckle LLP lawyers Matthew Walsh and Stephanie Brown advised on the deal. Matthew said: “Aaron and NVM have demonstrated great belief in Harry and Brendon’s vision with this successful investment and, under their expert leadership, the future looks incredibly bright for this exciting business.”

Aaron added: “Muckle were the team of choice for our investment into Ridge Pharma given their excellent track record in the pharmaceuticals sector.  Matthew and the team brought specialist advice alongside a commercial approach which facilitated both the technical legal elements and a smooth completion.”

Background information

NVM was also provided with:

  • Financial due diligence by Dow Schofield Watts (Jeff Gardner)
  • Commercial due diligence by Candesic (Dr Joe Taylor)
  • Management due diligence by Confidas People (Bruce Douglas)
  • VCT compliance by Philip Hare & Associates

 Ridge Pharma was provided with:

  • Legal advice by Gowling – Ian Piggin (Partner) and Roisin Bergin (Associate)